PL4164629T3 - Procyjanidyny do leczenia zaburzenia czynności śródbłonka spowodowanego przez COVID-19 - Google Patents
Procyjanidyny do leczenia zaburzenia czynności śródbłonka spowodowanego przez COVID-19Info
- Publication number
- PL4164629T3 PL4164629T3 PL21731159.6T PL21731159T PL4164629T3 PL 4164629 T3 PL4164629 T3 PL 4164629T3 PL 21731159 T PL21731159 T PL 21731159T PL 4164629 T3 PL4164629 T3 PL 4164629T3
- Authority
- PL
- Poland
- Prior art keywords
- covid
- procyanidins
- treatment
- endothelial dysfunction
- triggered
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/577—Malvaceae (Mallow family)
- A61K36/5777—Theobroma, e.g. cocao or cocoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20180939 | 2020-06-18 | ||
| PCT/EP2021/065482 WO2021254851A1 (en) | 2020-06-18 | 2021-06-09 | Procyanidins for the treatment of endothelial dysfunction triggered by covid-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4164629T3 true PL4164629T3 (pl) | 2024-11-18 |
Family
ID=71111247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21731159.6T PL4164629T3 (pl) | 2020-06-18 | 2021-06-09 | Procyjanidyny do leczenia zaburzenia czynności śródbłonka spowodowanego przez COVID-19 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20230233634A1 (pl) |
| EP (1) | EP4164629B1 (pl) |
| JP (1) | JP2023535870A (pl) |
| CN (1) | CN116033898A (pl) |
| AU (1) | AU2021291337A1 (pl) |
| BR (1) | BR112022025654A2 (pl) |
| CA (1) | CA3180707A1 (pl) |
| DK (1) | DK4164629T3 (pl) |
| ES (1) | ES2985604T3 (pl) |
| FI (1) | FI4164629T3 (pl) |
| HR (1) | HRP20241012T1 (pl) |
| HU (1) | HUE067661T2 (pl) |
| LT (1) | LT4164629T (pl) |
| PL (1) | PL4164629T3 (pl) |
| PT (1) | PT4164629T (pl) |
| RS (1) | RS65820B1 (pl) |
| SI (1) | SI4164629T1 (pl) |
| TW (1) | TWI888579B (pl) |
| WO (1) | WO2021254851A1 (pl) |
| ZA (1) | ZA202213765B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230233634A1 (en) * | 2020-06-18 | 2023-07-27 | Horphag Research Ip (Pyc) Ltd. | Procyanidins for the treatment of endothelial dysfunction triggered by covid-19 |
| GR1010617B (el) * | 2022-12-23 | 2024-01-25 | UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", | Αναστολεις της προλυλικης ολιγοπεπτιδασης (ρορ) για χρηση στην προληψη και στην αντιμετωπιση του συνδρομου οξειας αναπνευστικης δυσχερειας (ards) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1427100A (fr) | 1964-12-14 | 1966-02-04 | Ile De Rech Pharma Et Therapeu | Procédé pour l'obtention d'hydroxyflavanne-3-4-diols |
| US5720956A (en) | 1996-04-10 | 1998-02-24 | Rohdewald; Peter | Method of controlling the reactivity of human blood platelets by oral administration of the extract of the maritime pine (pycnogenol) |
| JP3260134B2 (ja) | 1999-10-08 | 2002-02-25 | 信孝 鈴木 | 月経困難症、子宮内膜症の治療薬 |
| AU2001282373A1 (en) * | 2000-05-26 | 2001-12-03 | Horphag Research Limited | Use of proanthocyanidins as an active ingredient of a stimulator and l-arginine or its salts as a source of nitric oxide to relieve symptoms of erectile dysfuntion |
| US20040137081A1 (en) | 2003-01-13 | 2004-07-15 | Peter Rohdewald | Attaining sexual wellness and health of the sexual vascular system with proanthocyanidins |
| ES2542985T3 (es) * | 2003-07-22 | 2015-08-13 | Kyowa Hakko Bio Co., Ltd | Composición preventiva o terapéutica para una enfermedad infecciosa vírica |
| JP2005314316A (ja) * | 2004-04-30 | 2005-11-10 | Kikkoman Corp | 抗ｓａｒｓコロナウイルス剤 |
| JP2007217410A (ja) * | 2006-01-20 | 2007-08-30 | Tsutomu Yoshida | 抗ウイルス組成物、それを含む抗ウィルス剤及び抗ウイルス機能性食品 |
| JP2007306872A (ja) * | 2006-05-19 | 2007-11-29 | Suntory Ltd | プロアントシアニジン含有茶飲料 |
| CN101401798A (zh) * | 2008-11-14 | 2009-04-08 | 江苏大学 | 一种原花青素泡腾片及其制作方法 |
| ES2720628T3 (es) * | 2011-08-10 | 2019-07-23 | Abro Biotec S L | Extracto de uva, complemento nutricional que lo comprende y su uso como ingrediente funcional |
| GB201413228D0 (en) * | 2014-07-25 | 2014-09-10 | Nugerontix Ltd | Polyphenol compositions |
| CN108159036A (zh) * | 2018-02-12 | 2018-06-15 | 成都图径生物科技有限公司 | 含茶氨酸、磷脂酰丝氨酸和原花青素的缓解视疲劳的组合物 |
| US11419847B2 (en) * | 2020-04-10 | 2022-08-23 | Matthias W. Rath | Pharmaceutical micronutrient composition and its use to simultaneously inhibit multiple cellular mechanisms of infectivity caused by coronavirus, its variants and mutants |
| US20210361700A1 (en) * | 2020-05-22 | 2021-11-25 | Trustees Of Tufts College | Nutritional supplement to combat covid-19 and aid vaccination |
| US20230233634A1 (en) * | 2020-06-18 | 2023-07-27 | Horphag Research Ip (Pyc) Ltd. | Procyanidins for the treatment of endothelial dysfunction triggered by covid-19 |
| CN116942835A (zh) * | 2023-05-09 | 2023-10-27 | 国药中生生物技术研究院有限公司 | 复合物及其用途 |
-
2021
- 2021-06-09 US US17/928,797 patent/US20230233634A1/en active Pending
- 2021-06-09 RS RS20240880A patent/RS65820B1/sr unknown
- 2021-06-09 EP EP21731159.6A patent/EP4164629B1/en active Active
- 2021-06-09 FI FIEP21731159.6T patent/FI4164629T3/fi active
- 2021-06-09 PT PT217311596T patent/PT4164629T/pt unknown
- 2021-06-09 DK DK21731159.6T patent/DK4164629T3/da active
- 2021-06-09 PL PL21731159.6T patent/PL4164629T3/pl unknown
- 2021-06-09 HU HUE21731159A patent/HUE067661T2/hu unknown
- 2021-06-09 BR BR112022025654A patent/BR112022025654A2/pt unknown
- 2021-06-09 JP JP2022576226A patent/JP2023535870A/ja active Pending
- 2021-06-09 CA CA3180707A patent/CA3180707A1/en active Pending
- 2021-06-09 AU AU2021291337A patent/AU2021291337A1/en active Pending
- 2021-06-09 HR HRP20241012TT patent/HRP20241012T1/hr unknown
- 2021-06-09 CN CN202180042723.6A patent/CN116033898A/zh active Pending
- 2021-06-09 ES ES21731159T patent/ES2985604T3/es active Active
- 2021-06-09 LT LTEPPCT/EP2021/065482T patent/LT4164629T/lt unknown
- 2021-06-09 WO PCT/EP2021/065482 patent/WO2021254851A1/en not_active Ceased
- 2021-06-09 SI SI202130173T patent/SI4164629T1/sl unknown
- 2021-06-15 US US17/347,879 patent/US20210393580A1/en active Pending
- 2021-06-16 TW TW110121965A patent/TWI888579B/zh active
-
2022
- 2022-12-20 ZA ZA2022/13765A patent/ZA202213765B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202207915A (zh) | 2022-03-01 |
| BR112022025654A2 (pt) | 2023-01-17 |
| CA3180707A1 (en) | 2021-12-23 |
| SI4164629T1 (sl) | 2024-10-30 |
| PT4164629T (pt) | 2024-08-02 |
| JP2023535870A (ja) | 2023-08-22 |
| WO2021254851A1 (en) | 2021-12-23 |
| HUE067661T2 (hu) | 2024-11-28 |
| DK4164629T3 (da) | 2024-09-09 |
| AU2021291337A1 (en) | 2023-01-05 |
| EP4164629A1 (en) | 2023-04-19 |
| HRP20241012T1 (hr) | 2024-10-25 |
| TWI888579B (zh) | 2025-07-01 |
| US20210393580A1 (en) | 2021-12-23 |
| RS65820B1 (sr) | 2024-09-30 |
| LT4164629T (lt) | 2024-08-26 |
| ES2985604T3 (es) | 2024-11-06 |
| CN116033898A (zh) | 2023-04-28 |
| US20230233634A1 (en) | 2023-07-27 |
| EP4164629B1 (en) | 2024-06-05 |
| FI4164629T3 (fi) | 2024-08-07 |
| ZA202213765B (en) | 2024-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2022039I2 (el) | Θεραπευτικες ενωσεις χρησιμες για την προφυλακτικη ή θεραπευτικη αγωγη μολυνσης ιου ηiv | |
| MX2016009013A (es) | Derivados de heterociclilo biciclicos como inhibores de cinasa-4 asociada al receptor de interleucina-1 (irak4). | |
| ZA202100272B (en) | Highly purified fucans for the treatment of fibrous adhesions | |
| MX2016013564A (es) | Inhibidores heterociclicos de cinasas. | |
| MX2018004643A (es) | Compuestos de benzolactama como inhibidores de la proteina cinasa. | |
| HUE068170T2 (hu) | Policiklusos karbamoil-piridon-származékok a HIV kezelésére | |
| MX2015008975A (es) | Analogos de tiadiazol y metodos para el tratamiento de afecciones relacionadas con deficiencia del gen de supervivencia de las neuronas motoras (smn). | |
| EP3449001A4 (en) | INHIBITION OF MIR-22-MIRNA BY APT-110 | |
| MX2018001992A (es) | Compuestos triciclicos heterociclicos como inhibidores de fosfoinositol 3-quinasa. | |
| MA51337A (fr) | Inhibiteurs spiro exo-aza de l'interaction ménine-mll | |
| EP3781574A4 (en) | MACROCYCLIC SPIROETHER AS MCL-1 INHIBITORS | |
| PH12016502246B1 (en) | Carboxamide derivatives | |
| PT4164629T (pt) | Procianidinas para o tratamento da disfunção endotelial desencadeada pela covid-19 | |
| MX381129B (es) | Inhibidores de dopamina-b-hidroxilasa. | |
| LT3709996T (lt) | Kumarino darinys, skirtas ląstelių proliferacijos sutrikimo terapijai arba profilaktikai | |
| EP3844166C0 (en) | SUBSTITUTED MACROCYCLES SUITABLE AS KINASE INHIBITORS | |
| HUE067197T2 (hu) | Készítmények patogének által okozott fertõzések kezelésére | |
| EP3419682C0 (en) | CRYSTALLIZATION INHIBITOR COMPOSITIONS FOR IMPLANTABLE UROLOGICAL DEVICES | |
| GB202400623D0 (en) | Anti-fungal composition dervied from hesperaloe | |
| MX2016013561A (es) | Activadores de herg policiclicos. | |
| IT201700085409A1 (it) | Composizione per il trattamento di infezioni causate da agenti patogeni | |
| PT3202772T (pt) | Cristal de um complexo de l-prolina/inibidor do cotransportador de sódio-glicose 2 | |
| MX378165B (es) | Compuesto de tiazolidinona y su uso en el tratamiento de trastornos psiquiátricos o neurológicos y de la inflamación, en particular de la neuroinflamación. | |
| PL3586832T3 (pl) | Kompozycja farmaceutyczna do leczenia zaparcia | |
| IL313109A (en) | Sco-spondin-derived polypeptides for treating biological barriers dysfunction |